Focus
CAR-T-cell therapy
LATEST
CAR T-Cell Therapy for Blood Cancer Rarely Linked to Other Cancers: Stanford Medicine Study
The FDA put a black-box warning on the treatment after receiving 11 reports of T-cell lymphomas in patients receiving it, but new research says the risk is low.
|
FDA Seeks New Boxed Warning for CAR-T Cancer Therapies After Cancer Risk Reports
However, the FDA said the benefits of the treatment still outweigh the risks.
|
CAR T-Cell Cancer Therapy Potentially Linked to Rare Blood Cancer, Experts Respond
CAR T therapies are currently used to treat blood cancers, including multiple myelomas, leukemias, and B-cell lymphomas.
|
